FDA Center for Drug Evaluation & Research Issues Warning Letter to New York Tong Ren Tang
November 04, 2026
November 04, 2026
WASHINGTON, Nov. 4 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Jing Cheong Asia Inc. dba New York Tong Ren Tang from its Center for Drug Evaluation and Research:
* * *
Recipient: Timothy Chuang, Chief Executive Officer, Jing Cheong Asia Inc. dba New York Tong Ren Tang, 4034 Main Street, Flushing, NY 11354, United States, help@nytrt.com
Issuing Office: Center for Drug Evalu . . .
* * *
Recipient: Timothy Chuang, Chief Executive Officer, Jing Cheong Asia Inc. dba New York Tong Ren Tang, 4034 Main Street, Flushing, NY 11354, United States, help@nytrt.com
Issuing Office: Center for Drug Evalu . . .